Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose vs PEG for Bowel Preparation in Low-risk Patients
NCT05648318Completed
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of lactulose in colonic neoplasms (CRC) (2 arms). Primary endpoint: Bowel preparation at 1 hour. Started Jan 2022; status: completed.
02
Drugs
lactulose
03
Conditions
colonic neoplasms (CRC)
Beyond the preview
Go deeper on NCT05648318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05648318.